CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0410
+0.0010 (2.50%)
At close: Feb 23, 2026
CERO Market Cap
CERO has a market cap or net worth of $1.18 million as of February 24, 2026. Its market cap has decreased by -68.75% in one year.
Market Cap
1.18M
Enterprise Value
8.86M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 1.18M, a decrease of -99.47%. That is a compound annual growth rate of -71.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.15M | -18.85% |
| Dec 31, 2025 | 1.41M | -87.73% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carisma Therapeutics | 1.66M |
| inTerra Resources | 1.49M |
| Exousia Pro | 1.48M |
| Evofem Biosciences | 1.19M |
| International Stem Cell | 1.16M |
| Eastgate Biotech | 1.06M |
| Halberd | 1.05M |
| Emmaus Life Sciences | 982.64K |